| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160880 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 07/20/2006 | US20060160862 Caspase inhibitors and uses thereof |
| 07/20/2006 | US20060160858 Administering N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide for treating ophthalmic disease which is age related macular degeneration, diabetic retinopathy, or neovascular glaucoma |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160853 2-[(4-Benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as nr2b receptor antagonists |
| 07/20/2006 | US20060160851 Substituted piperidine carbamates |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160842 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160821 N-[4-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenyl]-2-(4-chlorophenylaminocarbonylamino)-acetamide; thrombosis prevention |
| 07/20/2006 | US20060160820 Substituted piperazine carbamates |
| 07/20/2006 | US20060160819 Substitued piperazine carbamates |
| 07/20/2006 | US20060160813 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
| 07/20/2006 | US20060160804 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 07/20/2006 | US20060160801 Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 07/20/2006 | US20060160800 Morpholino-2-[6-(2-Ethoxy-phenyl)-pyridin-3-yl]-benzyl)-acetamide compound; as anti-proliferative agents, for treating mammals |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160794 Such as [1-(3,5-bis-trifluoromethylbenzyl)-5-imidazol-1-yl-1H-[1,2,3]triazol-4-yl]-[5-(2-chlorophenyl)-3-hydroxymethyl-isoxazol-4-yl]-methanone; for treatment of depression, anxiety, irritable bowel syndrome, and emesis |
| 07/20/2006 | US20060160790 Thioureas as factor Xa inhibitors |
| 07/20/2006 | US20060160786 e.g. 5-[3-[4-(3-fluoro-2-methylphenoxy)piperidin-1-yl]-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl]-2-methoxypyridine; treatment of arousal disorder, orgasmic disorder, sexual pain disorder and premature ejaculation, preterm labor, appetite and feeding disorders, dysmenorrhoea, congestive heart failure |
| 07/20/2006 | US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy |
| 07/20/2006 | US20060156488 For the dyeing of keratin |
| 07/20/2006 | CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | CA2594821A1 Process for preparing lansoprazole |
| 07/20/2006 | CA2594449A1 1,3-diaryl substituted ureas as modulators of kinase activity |
| 07/20/2006 | CA2594377A1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 07/20/2006 | CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues |
| 07/20/2006 | CA2593450A1 Indole derivatives for treating viral infections |
| 07/20/2006 | CA2593344A1 Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidine-1-carboxylic acid derivatives and related compounds |
| 07/20/2006 | CA2592723A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | CA2592611A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same |
| 07/20/2006 | CA2590898A1 3,4,(5)-substituted tetrahvdropyridines |
| 07/19/2006 | EP1681056A1 Process for preparing lansoprazole |
| 07/19/2006 | EP1680418A2 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/19/2006 | EP1680416A2 Naphthalene-1,5-disulfonic acid salts of a substituted 4-amino-1-(pyridylmethyl)piperidine compound |
| 07/19/2006 | EP1680415A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 07/19/2006 | EP1680414A2 Substituted indazole-o-glucosides |
| 07/19/2006 | EP1680408A2 Ccr3 receptor antagonists |
| 07/19/2006 | EP1680406A1 N-substituted benzene sulfonamides |
| 07/19/2006 | EP1680402A1 Derivatives of n-[[phenyl(piperidine-2-yl)methyl]benzamide, preparation method thereof and applications of same in therapeutics |
| 07/19/2006 | EP1680401A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 07/19/2006 | EP1680122A1 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for the treatment of cancer |
| 07/19/2006 | EP1680114A2 Triazole compounds and uses related thereto |
| 07/19/2006 | EP1680113A2 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications |
| 07/19/2006 | EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/19/2006 | EP1395575B1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1299361B1 Pyrazole derivatives |
| 07/19/2006 | EP1263740B1 Pyrimidine-4-one derivative as ldl-pla2 inhibitor |
| 07/19/2006 | EP1097927B1 Cyanoiminoquinoxaline derivatives |
| 07/19/2006 | EP0831923B1 Separation of active complexes |
| 07/19/2006 | CN1805957A Azetidine compounds |
| 07/19/2006 | CN1805952A Bicyclic indolyl derivatives and methods of their use as serotonergic agents |
| 07/19/2006 | CN1805951A Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase |
| 07/19/2006 | CN1805950A Method for preparing fused oxazinones |
| 07/19/2006 | CN1805943A Alpha substituted carboxylic acid as PPAR modulators |
| 07/19/2006 | CN1805940A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 07/19/2006 | CN1805929A Phosphodiesterase 4 inhibitors |
| 07/19/2006 | CN1805928A Prodrugs of mitotic kinesin inhibitors |
| 07/19/2006 | CN1805748A 2-aminopyrimidine derivatives as RAF kinase inhibitors |
| 07/19/2006 | CN1805747A 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 07/19/2006 | CN1805742A Cis-imidazolines as MDM2 inhibitors |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists |
| 07/19/2006 | CN1803794A Improved preparation and separated purification method of benzimidazole type proton pump inhibitors and precursor thereof |
| 07/19/2006 | CN1803793A Razole derivatives and application thereof |
| 07/19/2006 | CN1803137A Process for producing crystal |
| 07/19/2006 | CN1264839C Non-nucleoside reverse transcriptase inhibitors |
| 07/19/2006 | CN1264838C Indole derivatives for treating central nervous system disease |
| 07/19/2006 | CN1264837C Antimicrobial quinolones, their compositions and uses |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/19/2006 | CN1264825C Dihydro-benzo [b][1,4] diazepin-2-one derivative as mglur 2 antagonists II |
| 07/19/2006 | CN1264824C Quinazoline derivatives |
| 07/19/2006 | CN1264514C Pediatric formulation of gatifloxacin |
| 07/18/2006 | USRE39198 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078529 Imidazole derivatives |
| 07/18/2006 | US7078424 Central nervous system disorders; alopecia |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078419 Cytokine inhibitors |
| 07/18/2006 | US7078418 e.g., 2,6-bis(1-aziridino-1-hydroxyiminomethyl)pyridine; treating colon, stomach, lung, breast and uterus cancer |
| 07/18/2006 | US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 07/18/2006 | US7078415 1-(omego-substituted-2-[(hetero)arylcarbonylamino]alkanoyl)-4-(1-methylpiperidin-4-yl)piperidine derivatives; e.g., 1-[N-(Indole-6-carbonyl)-D-serinyl]-4-(1-methylpiperidin-4-yl)piperidine Hydrochloride |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078401 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 07/18/2006 | US7078397 Comprises thiadiazolidinedione-based insulin sensitizers (troglitazone); peroxisome proliferator-activated receptors |
| 07/18/2006 | CA2407416C Alkynyl phenyl heteroaromatic glucokinase activators |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/18/2006 | CA2269053C Crystals of benzimidazole derivatives and their production |
| 07/18/2006 | CA2242425C Quinazoline derivatives as vegf inhibitors |
| 07/13/2006 | WO2006074270A2 Synthesis of ccr5 receptor antagonists |
| 07/13/2006 | WO2006074264A2 Preparation of ketone amides |
| 07/13/2006 | WO2006074025A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 07/13/2006 | WO2006073973A2 Novel benzylamine derivatives as cetp inhibitors |